A Study of Zanubrutinib in Combination With Polatuzumab Vedotin, Bendamustine and Rituximab in the Treatment of Relapsed/Refractory Diffuse Large B-cell Lymphoma
Clinical trial NCT06554600 · RECRUITING
Trial details
- NCT number
- NCT06554600
- Sponsor
- Second Affiliated Hospital, Zhejiang University, School of Medicine
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-31
- Primary completion
- 2026-08-31
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.